Danh mục

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

Số trang: 12      Loại file: pdf      Dung lượng: 1.48 MB      Lượt xem: 8      Lượt tải: 0    
10.10.2023

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Although early tumor shrinkage (ETS) is a predictor of improved overall survival (OS), the association between ETS and health-related quality of life (HRQOL) remains unclear for patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab plus chemotherapy.
Nội dung trích xuất từ tài liệu:
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

Tài liệu được xem nhiều: